
.@HealthpointUAE, part of @M42Health, has opened a dedicated Cleft Lip and Palate Clinic in Abu Dhabi, bringing surgical, dental, hearing, and speech services together to provide coordinated care for patients from infancy through adulthood.

Advancing innovation in healthcare for the people and the planet.

.@HealthpointUAE, part of @M42Health, has opened a dedicated Cleft Lip and Palate Clinic in Abu Dhabi, bringing surgical, dental, hearing, and speech services together to provide coordinated care for patients from infancy through adulthood.

Healthpoint, part of M42, has opened its dedicated Cleft Lip and Palate Clinic in Abu Dhabi. Located at Zayed Sports City, the clinic brings reconstructive surgery, dentistry, ENT, audiology and speech therapy all together under one pathway. Designed for patients of all ages and nationalities, our multidisciplinary team provides personalized, lifelong support from early newborn feeding guidance to long term follow up care. To find out more, visit the link m42.ae/media-resources/news/… #M42 #Healthpoint

Every genome adds to the understanding of the population’s health, helping care for each individual more personally. With a million Emirati Genome Program participants, these collective insights are advancing preventative and personalised healthcare for UAE Nationals.

The National Genomics Masterplan 2026-2031 sets out how the UAE will enhance healthcare services through 12 programmes, bringing together prevention, diagnosis and treatment to support earlier insights, more personalised care and better health outcomes for UAE Nationals.

During the critical first weeks of a child’s life, the right information can save lives. The Newborn Genetic Screening Programme can detect signs of inherited conditions before symptoms appear, enabling timely intervention and supporting better health from the very beginning.

That’s a wrap on an incredible week at the 46th ICMM World Congress of Military Medicine Abu Dhabi 2026. Over the past five days, our team connected with global healthcare leaders to share how our health intelligence ecosystem combines genomics, AI and digital health to transform medical readiness and predictive care. While the event has come to a close, our mission continues. We remain committed to bridging military and civilian healthcare and pushing the boundaries of precision medicine every day. Thank you to everyone who visited the M42 stand and joined the conversation. #ICMM #M42

Connecting global leaders at ICMM 2026 in Abu Dhabi. We welcomed His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence, to our stand and were honored to discuss the UAE’s healthcare transformation, M42’s contribution to health progress and our collaboration with partners in the UAE to advance healthcare innovation. #M42 #ICMM2026

Clinicians spend over a third of their day navigating medical records and writing chart notes. What if AI could change that? At Sheikh Sultan Bin Zayed Hospital, the OSSI AI tool is listening to patient-doctor conversations, understanding clinical context and creating accurate chart notes. Watch Dr. Maaz Shaikh, Vice President of Product Management at M42, explain how lifting the workload of documentation gives doctors back their most valuable asset which is time. Helping build deeper connections and focus entirely on patient care. #M42 #ICMM #OSSI

Bringing people together around the future of health at ICMM 2026. Our M42 leaders - Sheikh Zayed bin Mansour bin Tahnoon Al Nahyan, Advisor to the GCEO, M42; Dr. Moza Ajaif Al Zaabi, CEO, Sheikh Sultan bin Zayed Hospital; Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions, M42; Dr. Ali Anees, Chief Operating Officer UAE & Bahrain, M42; and Faisal Al Mulla, Senior Vice President Group Human Capital - met with stakeholders to explore how genomics, AI and health intelligence are bridging military and civilian care to strengthen medical readiness. #M42 #ICMM

Shaping the future of global health at ICMM 2026. We were honoured to welcome H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs and Chairman of the Board of Trustees of Erth Zayed Philanthropies, highlighting our vision for advancing healthcare innovation, impact and medical readiness. #M42 #ICMM

At M42, we are dedicated to unlocking insights through biobanking and advanced health data to understand and mitigate risks, and protect the health of frontline workers. Watch Paul Downey, General Manager of Abu Dhabi Biobank, discuss the vital connection of research, healthcare and frontline wellbeing at ICMM 2026. #ICMM #M42

Highlights of Day 1 at the 46th ICMM World Congress of Military Medicine. A day of conversations, knowledge sharing and collaboration around the future of healthcare. From genomics and precision medicine to AI, health intelligence and military-civilian partnerships, we explored how innovation can help predict, prevent and strengthen care. We look forward to continuing the conversations and exploring new opportunities to build more resilient healthcare systems. #M42 #ICMM

A milestone in advanced healthcare for the Northern Emirates. Sheikh Sultan bin Zayed Hospital, part of M42, has successfully performed the Northern Emirates first hypoglossal nerve stimulation implant for the treatment of obstructive sleep apnea. Led by Dr. Eyad Shitawi, Consultant ENT Surgeon, the procedure introduces an advanced treatment option for eligible patients who are unable to tolerate CPAP therapy, helping improve breathing during sleep and quality of life. This achievement reflects our continued commitment to bringing specialised medical expertise and innovative treatment options closer to the communities we serve. Click the link to read the full announcement and explore our latest clinical innovations m42.ae/media-resources/news/… #M42 #SheikhSultanBinZayedHospital

A major milestone for specialized healthcare. Sheikh Sultan bin Zayed Hospital has successfully performed it’s first hypoglossal nerve stimulation implant for obstructive sleep apnea on a 44-year-old Emirati patient. This achievement highlights our continuous commitment to advancing patient-centered treatment alternatives. By combining advanced clinical expertise with innovative surgical solutions, we are expanding access to specialized care and improving patient quality of life. Click the link to read the full announcement and explore our latest clinical innovations m42.ae/media-resources/news/… #M42 #SheikhSultanBinZayedHospital

AI isn't here to replace doctors, but to augment their expertise and help them spend more time where it matters most: with their patients. In the latest Beyond Bounds discussion, Dr. Maaz Shaikh explores how AI can reduce administrative burden, strengthen the human connection in healthcare and support patient care. Read the full article and stay ahead of what's next with Beyond Bounds. Find out more through the link beyondbounds.m42.ae/articles… #BeyondBounds #M42 #ArtificialIntelligence #DigitalHealth #FutureOfHealthcare #PrecisionMedicine

We are proud to announce a new Memorandum of Understanding with ADCAN Pharma to expand advanced oncology manufacturing and clinical research in the UAE. Signed at the Abu Dhabi Future Health Summit 2026 by Dr. Fokion Sinis, CEO of ADCAN Pharma and Dr. David Kavanagh, Acting Chief Operating Officer of M42’s Integrated Health Solutions, this agreement brings together local manufacturing and clinical research expertise to support the UAE’s life sciences sector and its links with global markets. Through this partnership, M42 and ADCAN Pharma will explore contract development and manufacturing opportunities through Glenmark Pharmaceuticals, focusing on secondary packaging and pharmaceutical supply for export following a successful quality examination of ADCAN Pharma’s manufacturing facility. The next phase will support the UAE registration of an advanced antibody-drug conjugate oncology product, while ADCAN Pharma collaborates with M42’s clinical research organization, IROS to connect local clinical trial activities directly with pharmaceutical manufacturing. #M42 #ADCANPharma #Oncology #ClinicalResearch #LifeSciences #ADFHS2026